Biapenem （GMP) -
Biapenem （GMP) For Sale, Most Competitive Price, Fast Delivery, Custom Service, Wholesale Biapenem （GMP), Made in China, High Quality Products!, China Biapenem, 120410-24-4 Supplier, Manufacturer.Biapenem
CAS:
120410-24-4
Introduction:
Biapenem is a new parenteral carbapenem antibacterial agent with a broad spectrum of in vitro antibacterial activity encompassing many Gram-negative and Gram-positive aerobic and anaerobic bacteria, including species producing β-lactamases. It was approved in Japan in 2001.
Simcere's Biapenem API:
In 2008, Simcere抯 Anxin is the first-to-market Biapenem injection in China.
The API materials and preparations of Biapenem are both successfully passed and received SFDA GMP certification.
Some inspection data
Specification CP/Sterile bulk drugs
Properties White or yellow crystalline powder
Specific rotation -33.0?
Acidity 5.3
Loss on drying 0.04%
Residue on ignition 0.01%
Chloride 0.05% max
Heavy metals 10ppm max
Bacterial endotoxin 0.5EU/mg max
Assay 97% min
Simcere Pharmaceutical Group
Address: No.699-18, Xuanwu Avenue Nanjing, P. R. China, Nanjing, Jiangsu, China, 210042
Tel: +86 (25) 8556 6666-8851
Founded in 1995 with a vision to establish a company that would in turn help create a healthier China, Simcere Pharmaceutical Group has become a leading manufacturer and supplier of drugs in the rapidly growing China pharmaceutical market, we now have seven certified Good Manufacturing Practices ("GMP") manufacturing facilities and three research and development center and over 4,000 employees. Now Simcere has more than 20 Innovative Pharmaceuticals which are under development, and they all have independent intellectual property rights. In 2010, From them we submited five clinical trial applications to the SFDA.
In 2007 Simcere successfully landed the New York Stock Exchange (ticker symbol SCR) as the first one in mainland China's chemical and biological drugs NYSE-listed company. Simcere is actively increasing our collaborations with international companies (such as Bristol-Myers Squibb Company) to develop new drugs. August 2011, Simcere signed a cooperation framework agreement with Merck to establish a company, provide patients with more high-quality drugs.
Simcere has more than 20 kinds of bulk drug products have passed the GMP certification. Their preparations are saled in China for many years. The raw materials and preparations of Montmorillonite both successfully passed and received EU GMP certification.
Simcere API's advantage comes from good quality. We have a very strict and continuous improvement of the quality management system. This effectively ensures verification from production equipment, raw materials, processing, semi-finished and finished product to ensure stable production process and quality.
Simcere is committed to providing our customers with excellent quality products, simple and efficient service, and Simcere has been concerned with environmental, health and safety issues.
We are looking forward to become a trusty cooperator in the pharmaceutical industry.
